The Language division of Globomics LLC provides
translation and other language services in many fields, specially in scientific, academic and biomedical subjects
with a particular focus on public health. We offer quality translations between
the main official languages of sub-Saharan Africa, Latin America and the
Caribbean: English, French, Spanish and Portuguese. We also translate to/from most languages in
the world.
We guarantee timely delivery of all translation projects.
Globomics
LLC is a corporate member of the American Translators Association and of
ProZ.com, the largest professional translation portal.
Globomics LLC has pre-selected a core
group of experienced translators and
reviewers/proofreaders, who are often also
experts in their field. These language
specialists have a sophisticated understanding of the technical and
scientific aspects of your source documents.
Globomics LLC has a thorough quality
assurance system in place for its translation projects. Barring compelling
circumstances, all our linguists are translating into their native or daily
working language.
Upon request, we can also offer other services such
as additional reviews, back-translation and terminology research. In addition, Globomics
offers gist translations and summaries of documents.
Please contact us with a brief description of your translation project through the form provided under clients.
Globomics
LLC
PO BOX 2543
Decatur GA 30031-2543
(678) 732-9516
FAX (678) 306-1790
translate,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consent,sop,Globomics,Health Translation,consultant,consultancy,health,public health,global health,international health,science,international,medicine,medical,HIV,AIDS,antiretroviral therapy,antiretroviral,resistance,biology,laboratory,molecular biology,Africa,drugs,pharma,pharmacy,pharmaceutical,immunology,hematology,scientific,biotechnology,biotech,biomedical,tuberculosis,malaria,infectious diseases,development,NGO,vaccine,vaccination,epidemiology,microbiology,biosafety,ethical,IRB,informed consent,human subject protection,confidential,confidentiality,clinical trials,implementer,global fund,market research,PEPFAR,GFATM,evaluation,assessment,translate,translation,french,spanish,portuguese,public
health,medical,global,international,clinical trials,informed
consent,sop,Globomics,Health
Translation,consultant,consultancy,health,public health,global
health,international
health,science,international,medicine,medical,HIV,AIDS,antiretroviral
therapy,antiretroviral,resistance,biology,laboratory,molecular
biology,Africa,drugs,pharma,pharmacy,pharmaceutical,immunology,hematology,scientific,biotechnology,biotech,biomedical,tuberculosis,malaria,infectious
diseases,development,NGO,vaccine,vaccination,epidemiology,microbiology,biosafety,ethical,IRB,informed
consent,human subject protection,confidential,confidentiality,clinical
trials,implementer,global fund,market
research,PEPFAR,GFATM,evaluation,assessment,translate,translation,french,spanish,portuguese,public
health,medical,global,international,clinical trials,informed
consent,sop,Globomics,Health
Translation,consultant,consultancy,health,public health,global
health,international
health,science,international,medicine,medical,HIV,AIDS,antiretroviral
therapy,antiretroviral,resistance,biology,laboratory,molecular
biology,Africa,drugs,pharma,pharmacy,pharmaceutical,immunology,hematology,scientific,biotechnology,biotech,biomedical,tuberculosis,malaria,infectious
diseases,development,NGO,vaccine,vaccination,epidemiology,microbiology,biosafety,ethical,IRB,informed
consent,human subject protection,confidential,confidentiality,clinical
trials,implementer,global fund,market
research,PEPFAR,GFATM,evaluation,assessment,translate,translation,french,spanish,portuguese,public
health,medical,global,international,clinical trials,informed
consent,sop,Globomics,Health
Translation,consultant,consultancy,health,public health,global
health,international
health,science,international,medicine,medical,HIV,AIDS,antiretroviral
therapy,antiretroviral,resistance,biology,laboratory,molecular
biology,Africa,drugs,pharma,pharmacy,pharmaceutical,immunology,hematology,scientific,biotechnology,biotech,biomedical,tuberculosis,malaria,infectious
diseases,development,NGO,vaccine,vaccination,epidemiology,microbiology,biosafety,ethical,IRB,informed
consent,human subject protection,confidential,confidentiality,clinical
trials,implementer,global fund,market
research,PEPFAR,GFATM,evaluation,assessment,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consent,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consent,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consent,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consent,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consent,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consent,translation,french,spanish,portuguese,public health,medical,global,international,clinical trials,informed consentt,french,spanish,portuguese,french,spanish,portuguese,french,spanish,portuguese,french,spanish,portuguese